Accreditation and Designation Statements

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credit for completing this activity.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Identify symptoms specific to CIC to distinguish it from IBS-C.
  • Diagnosis CIC or IBS-C based on patients’ presenting symptoms.
  • Describe the Rome IV criteria for CIC and IBS-C, and demonstrate how disease severity affects patient QOL.
  • Recognize the clinical guidelines for non-pharmacologic and pharmacologic options to treat patients with CIC and IBS-C.

Start Date : 12/15/16
Expiration Date: 12/14/17

Program description/need

This video webcast through a combination of presentations, patient videos, and other learning modalities, will seek to improve clinician competence in managing patients with IBS-C and CIC.

  • Faculty and Planning Committee

  • Dean Beals
  • President & CEO
  • DKBmed
  • New York, NY

  • Rachel Deerr
  • Senior Program Manager
  • DKBmed
  • New York, NY

  • Stan J. Pogroszewski, JD
  • COO/Director Compliance
  • DKBmed
  • New York, NY

  • Deborah Paschal, CRNP
  • Clinical Nurse Practitioner
  • Philadelphia, PA

  • Gregg Sherman, MD
  • National Association for Continuing Education
  • Plantation, FL

  • Nimish Vakil, MD, FACP, FACG, AGAF, FASGE
  • Clinical Adjunct Professor
  • University of Wisconsin
  • Madison, Wisconsin

Target Audience
Nurse Practitioners, Physician Assistants, Physicians

Faculty Disclosure Policy
It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Faculty Disclosures

  • Mr. Beals has no financial relationships to disclose.
  • Mr. Pogroszewski has no financial relationships to disclose.
  • Ms. Deerr has no financial relationships to disclose.
  • Dr. Sherman has no financial relationships to disclose.
  • Ms. Paschal has no financial relationships to disclose.
  • Dr. Vakil received an advisory board consulting fee from Ironwood Pharmaceuticals

How To Obtain Your CME Certificate:
There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test (with a passing score of 70%) and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

Hardware & Software Requirements

  • PC: Internet Explorer (v9 or greater), Chrome or Firefox
  • MAC: Safari
  • Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.
Commercial Support. This activity is supported by an independent educational grant from Allergen Inc.